InsidersTradesSigma
Track the 셀트리온제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has logged 2 reports. Market capitalisation: €1,785.8bn. The latest transaction was reported on 3 April 2026 (Purchase). Among the most active insiders: 김주범. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Celltrion Healthcare is a South Korean pharmaceutical company focused on the development and manufacturing of biosimilar drugs. It is listed on the Korea Exchange, XKRX.